Subscribe to magazine
Subscribe to newsletters
Computed Tomography (CT)
Magnetic Resonance Imaging (MRI)
Radiation Dose management
Intravascular imaging systems
Peripheral Artery Disease
Leads, implantable devices
Implantable cardioverter defibrillators (ICD)
Cardiac resynchronization therapy devices (CRT)
Heart Valve Technology
Left atrial appendage (LAA) occluders
Structural heart occluders/closure devices
Clinical decision support
51 Sawyer Road, Suite 200
Waltham, , MA 02453-3448
July 12, 2016
Alere Initiating Voluntary Recall of INRatio and INRatio2 PT/INR Monitor System
July 12, 2016 — Following a collaborative process with the U.S. Food and Drug Administration (FDA), Alere Inc.
Point of Care Testing
February 03, 2016
Abbott Acquires Alere to Expand Point-of-Care Diagnostics Offerings
Abbott and Alere Inc. announced a definitive agreement for Abbott to acquire Alere. Under the terms of the agreement,...
Photo courtesy of Alere
December 16, 2014
Alere Initiates Correction for Use of Alere INRatio and INRatio2 PT/INR Monitor Systems
Alere Inc. has initiated a voluntary correction to inform United States users of the Alere INRatio and INRatio 2 PT/INR...
July 16, 2012
FDA Class I Recall Made for Alere Triage Troponin Tests
July 16, 2012 — The U.S. Food and Drug Administration (FDA) notified healthcare professionals of a Class I recall of...
Scranton Gillette Communications
. All Rights Reserved.